Evidence map›Paper›PMID 30275329›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

Proinsulin C-peptide is an autoantigen in people with type 1 diabetes.

Michelle So, Colleen M Elso, Eleonora Tresoldi, Miha Pakusch, Vimukthi Pathiraja, John M Wentworth, Leonard C Harrison, Balasubramanian Krishnamurthy, Helen E Thomas, Christine Rodda and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 63 citations in OpenAlex.

  1. Review
  2. Article
  3. [Role of HLA genetic variants in autoimmune diseases].Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Ultrasensitive Hierarchical AuNRs@SiOInternational journal of nanomedicine · 2024
    Article
  14. A minority of proliferating human CD4Frontiers in immunology · 2024
    Article
  15. Article
  16. Review
  17. Review
  18. Islet-specific CD8Immunology and cell biology · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Michelle SoImmunology and Diabetes Unit, St. Vincent's Institute of Medical Research, Fitzroy, VIC 3065, Australia.
Colleen M ElsoImmunology and Diabetes Unit, St. Vincent's Institute of Medical Research, Fitzroy, VIC 3065, Australia.
Eleonora TresoldiImmunology and Diabetes Unit, St. Vincent's Institute of Medical Research, Fitzroy, VIC 3065, Australia.
Miha PakuschImmunology and Diabetes Unit, St. Vincent's Institute of Medical Research, Fitzroy, VIC 3065, Australia.
Vimukthi PathirajaImmunology and Diabetes Unit, St. Vincent's Institute of Medical Research, Fitzroy, VIC 3065, Australia.
John M WentworthDepartment of Population Health and Immunity Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia.ORCID 0000-0002-5197-3529
Leonard C HarrisonDepartment of Population Health and Immunity Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia.ORCID 0000-0002-2500-8944
Balasubramanian KrishnamurthyImmunology and Diabetes Unit, St. Vincent's Institute of Medical Research, Fitzroy, VIC 3065, Australia.
Helen E ThomasImmunology and Diabetes Unit, St. Vincent's Institute of Medical Research, Fitzroy, VIC 3065, Australia.
Christine RoddaWestern Centre for Health Research and Education, University of Melbourne, Western Clinical School, Sunshine Hospital, St. Albans, VIC 3021, Australia.
Fergus J CameronDepartment of Endocrinology and Diabetes, Royal Children's Hospital, Murdoch Children's Research Institute, Parkville, VIC 3052, Australia.
Jacinta McMahonImmunology and Diabetes Unit, St. Vincent's Institute of Medical Research, Fitzroy, VIC 3065, Australia.
Thomas W H KayImmunology and Diabetes Unit, St. Vincent's Institute of Medical Research, Fitzroy, VIC 3065, Australia.
Stuart I ManneringImmunology and Diabetes Unit, St. Vincent's Institute of Medical Research, Fitzroy, VIC 3065, Australia; smannering@svi.edu.au.ORCID 0000-0003-3497-3559
St Vincents Institute of Medical Research · AUThe University of Melbourne · AUWalter and Eliza Hall Institute of Medical Research · AURoyal Children's Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type 1 diabetes (T1D) is an autoimmune disease in which insulin-producing beta cells, found within the islets of Langerhans in the pancreas, are destroyed by islet-infiltrating T cells. Identifying the antigenic targets of beta-cell reactive T cells is critical to gain insight into the pathogenesis of T1D and develop antigen-specific immunotherapies. Several lines of evidence indicate that insulin is an important target of T cells in T1D. Because many human islet-infiltrating CD4

Indexed as

AdolescentAdultAutoantigensCD4-Positive T-LymphocytesCells, CulturedChildChild, PreschoolC-PeptideDiabetes Mellitus, Type 1HLA AntigensHumansIslets of LangerhansMiddle AgedProinsulinYoung AdultAutoantigensC-PeptideHLA AntigensProinsulinCD4+ T cellsepitopeHLAproinsulintype 1 diabetes

Identifiers

PMID30275329
PMCPMC6196477
OpenAlexW2895067267

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.